iBio was founded in 2008 and is headquartered in Newark, US

iBio has an office in Newark

Newark, US (HQ)

100 9 Innovation Way

iBio's revenue was reported to be $37 k in Q3, 2017

USD

## Revenue (Q3, 2017) | 37 k |

## EBIT (Q3, 2017) | (3.9 m) |

## Market capitalization (25-Jul-2017) | 31 m |

## Cash (31-Mar-2017) | 12.4 m |

iBio's current market capitalization is $31 m.

- Source: SEC Filings

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## Revenue | 205 k | 1.9 m | 948 k |

## Revenue growth, % | 803% | (49%) | |

## R&D expense | 1.9 m | 3.5 m | 3.2 m |

## General and administrative expense | 3.9 m | 5 m | 7.7 m |

## Operating expense total | 4 m | 8.5 m | 10.8 m |

## EBIT | (3.8 m) | (6.7 m) | (9.9 m) |

## EBIT margin, % | (1873%) | (360%) | (1044%) |

## Interest expense | (807 k) | ||

## Interest income | 8 k | 9 k | 22 k |

## Net Income | (3.7 m) | (6.6 m) | (10.7 m) |

USD | Q3, 2014^{} | Q1, 2014^{} | Q3, 2015^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2016^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 819 k | 349 k | 160 k | 134 k | 379 k | 135 k | 75 k | 37 k | |

## R&D expense | 343 k | 1.2 m | 815 k | 551 k | 704 k | 1 m | |||

## General and administrative expense | 951 k | 1.1 m | 1.2 m | 1.4 m | 1.7 m | 2.4 m | 2.5 m | 2.4 m | 2.8 m |

## Operating expense total | 1.3 m | 2.2 m | 2 m | 2 m | 2.4 m | 3.5 m | 2.5 m | 2.4 m | 2.8 m |

## EBIT | (1.3 m) | (1.4 m) | (1.7 m) | (1.8 m) | (2.3 m) | (3.1 m) | (3.2 m) | (3.3 m) | (3.9 m) |

## EBIT margin, % | (173%) | (484%) | (1133%) | (1682%) | (811%) | (2336%) | (4433%) | (10638%) | |

## Interest expense | (323 k) | (483 k) | (483 k) | (481 k) | |||||

## Interest income | 3 k | 1 k | 2 k | 2 k | 2 k | 5 k | 13 k | 12 k | 8 k |

## Net Income | (1.3 m) | (1.4 m) | (1.7 m) | (1.8 m) | (2.2 m) | (3.6 m) |

- Source: SEC Filings

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## Cash | 3.6 m | 9.5 m | 23 m |

## Inventories | 118 k | 182 k | 264 k |

## Current Assets | 3.9 m | 10.1 m | 23.9 m |

## PP&E | 6 k | 13 k | 25.6 m |

## Total Assets | 6.5 m | 12.5 m | 51.6 m |

## Accounts Payable | 297 k | 1.1 m | 1.2 m |

## Current Liabilities | 2.3 m | ||

## Total Liabilities | 27.6 m | ||

## Additional Paid-in Capital | 47.2 m | 59 m | 67.5 m |

## Retained Earnings | (41.2 m) | (47.8 m) | (57.6 m) |

## Total Equity | 6.1 m | 11.2 m | 24 m |

## Financial Leverage | 1.1 x | 1.1 x | 2.1 x |

USD | Q3, 2014^{} | Q1, 2014^{} | Q3, 2015^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2016^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Cash | 4.3 m | 3.5 m | 8.1 m | 8.4 m | 6.7 m | 21.9 m | 20.1 m | 16.3 m | 12.4 m |

## Current Assets | 5.5 m | 4.1 m | 9 m | 9.1 m | 7.2 m | 22.7 m | 20.5 m | 16.7 m | 13 m |

## PP&E | 7 k | 20 k | 14 k | 10 k | 14 k | 25.8 m | 25.6 m | 25.5 m | 25.8 m |

## Total Assets | 8.2 m | 6.7 m | 11.4 m | 11.4 m | 9.4 m | 50.7 m | 48.1 m | 44.2 m | 40.7 m |

## Accounts Payable | 1.1 m | 516 k | 815 k | 1.3 m | 1.6 m | 979 k | 731 k | 1.4 m | |

## Current Liabilities | 1.2 m | 2.4 m | 2.2 m | 1.9 m | 2.6 m | ||||

## Additional Paid-in Capital | 47 m | 48 m | 56.1 m | 59.4 m | 59.7 m | 63.1 m | 67.7 m | 68 m | 80.7 m |

## Retained Earnings | (40.1 m) | (42.6 m) | (45.9 m) | (49.6 m) | (51.9 m) | (54.9 m) | (60.7 m) | (63.9 m) | (67.8 m) |

## Total Equity | 7 m | 5.4 m | 10.2 m | 9.8 m | 7.9 m | 22.9 m | 20.7 m | 17.1 m | 12.9 m |

## Financial Leverage | 1.2 x | 1.2 x | 1.1 x | 1.2 x | 1.2 x | 2.2 x | 2.3 x | 2.6 x | 3.1 x |

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## Net Income | (3.7 m) | (6.6 m) | (10.7 m) |

## Depreciation and Amortization | 361 k | 363 k | 940 k |

## Inventories | 97 k | (64 k) | (82 k) |

## Accounts Payable | 56 k | 806 k | (125 k) |

## Cash From Operating Activities | (4.1 m) | (4.7 m) | (8.1 m) |

## Cash From Investing Activities | (259 k) | (215 k) | (68 k) |

## Cash From Financing Activities | 3.6 m | 10.9 m | 21.7 m |

## Interest Paid | 485 k |

USD | Q3, 2014^{} | Q1, 2014^{} | Q3, 2015^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2016^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (1.3 m) | (1.4 m) | (1.7 m) | (1.8 m) | (2.2 m) | (3.6 m) | |||

## Accounts Payable | 1.1 m | 516 k | 815 k | 1.3 m | 1.6 m | 979 k | 731 k | 1.4 m |

USD | Y, 2017 |
---|---|

## Revenue/Employee | 5.3 k |

## Financial Leverage | 3.1 x |